Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis

被引:76
作者
Yeatman, CF
Jacobs-Helber, SM
Mirmonsef, P
Gillespie, SR
Bouton, LA
Collins, HA
Sawyer, ST
Shelburne, CP
Ryan, JJ
机构
[1] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA 23298 USA
关键词
interleukin; 4; 10; mast cells; apoptosis; allergy;
D O I
10.1084/jem.192.8.1093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells are found in connective and mucosal tissues throughout the body. Their activation via immunoglobulin E (IgE)-antigen interactions is promoted by T helper cell type 2 (Th2) cytokines and leads to the sequelae of allergic disease. We now report a mechanism by which Th2 cytokines can regulate mast cell survival. Specifically, we find that interleukin (IL)-4 and IL-10 induce apoptosis in IL-3-dependent bone marrow-derived mast cells and peritoneal mast cells. This process required 6 d of costimulation with IL-3, IL-4, and IL-10, and expression of signal transducer and activator of transcription 6 (Stat6). Apoptosis was coupled with decreased expression of bcl-x(L) and bcl-2. While this process occurred independent of the Fas pathway, culture in IL-3+IL-4+IL-10 greatly sensitized mast cells to Fas-mediated death. Additionally, we found that IgE cross-linkage or stimulation with stem cell factor enhanced the apoptotic abilities of IL-4 and IL-10. Finally, IL-3-independent mastocytomas and mast cell lines were resistant to apoptosis induced by IL-3+IL-4+IL-10. These data offer evidence of Th2 cytokine-mediated homeostasis whereby these cytokines both elicit and limit allergic responses. Dysregulation of this pathway may play a role in allergic disease and mast cell tumor survival.
引用
收藏
页码:1093 / 1103
页数:11
相关论文
共 36 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] BEFUS AD, 1979, IMMUNOLOGY, V38, P95
  • [3] ACTIVATED MAST-CELLS PRODUCE INTERLEUKIN-13
    BURD, PR
    THOMPSON, WC
    MAX, EE
    MILLS, FC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) : 1373 - 1380
  • [4] Chen XJ, 1999, IMMUNOLOGY, V96, P544
  • [5] COX G, 1996, AM J PHYSIOL, V271, P566
  • [6] Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
  • [7] A SURVEY OF THE NUMBER AND DISTRIBUTION OF MAST-CELLS IN THE SKIN OF PATIENTS WITH MAST-CELL DISORDERS
    GARRIGA, MM
    FRIEDMAN, MM
    METCALFE, DD
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (03) : 425 - 432
  • [8] Gooch JL, 1998, CANCER RES, V58, P4199
  • [9] INTERLEUKIN-4 AS AN ESSENTIAL FACTOR FOR INVITRO CLONAL GROWTH OF MURINE CONNECTIVE TISSUE-TYPE MAST-CELLS
    HAMAGUCHI, Y
    KANAKURA, Y
    FUJITA, J
    TAKEDA, S
    NAKANO, T
    TARUI, S
    HONJO, T
    KITAMURA, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) : 268 - 273
  • [10] Hartmann K, 1997, J IMMUNOL, V159, P4006